SESSION TITLE: Procedures 2
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Wednesday, October 26, 2016 at 01:30 PM - 02:30 PM
PURPOSE: Transthoracic needle aspiration (TTNA) is a common procedure done for indeterminate pulmonary lesions. Pulmonary haemorrhage is the second most common complication associated with TTNA. Antiplatelets have proven life-saving benefits in patients with ischemic heart disease and cerebrovascular conditions. However they are associated with an increased risk of bleeding. Patients on these medications are prevalent, yet there is no clear guideline as to the cessation or continuation of antiplatelet therapy for TTNA as the risk benefit ratio has not been clearly defined. The aims of this study is to determine if the use of antiplatelets during TTNA increases the risk of bleeding and if withholding these medications would result in ischemic complications such as acute myocardial infarct or cerebrovascular events.